GROSSPATTERN / DETERMINISTIC INSIGHT

Leverage direction reversed

ANI PHARMACEUTICALS INC · Leverage Reversal · effective Jun 30, 2026

EVIDENCE CONFIDENCE100%1 independent group · 34 governed parents

LIFECYCLEINTENSIFIED

HISTORICAL30th pct

PEER DIVERGENCE—

PERSISTENCE5 periods

CURRENTNESSCURRENT/MATCH

VALUE GATESURFACE ELIGIBLE

Why this matched

Inspectable conditions

Each condition comes from governed filing metrics. Context does not assert causality or predict price.

Dimension	Recent direction	Multi-period	Magnitude	Historical percentile
Balance Sheet Leverage	IMPROVING	IMPROVING	-35.5640	30.000

Method and lineage

DEFINITION[email protected][email protected]

EVIDENCE1 independent / 34 parentsRights, quality, lineage, currentness, and publication gates passed.

PROFILEGeneral CorporateProfile-specific interpretation.